Bavarian Nordic gets U.S. contract; Price of Novartis' Bexsero could be problematic;

> Los Angeles health officials and charities are offering free meningitis vaccines after a man died of the disease last week. News

> Bavarian Nordic has secured a $228 million supply deal with the U.S. for the smallpox vaccine that accounts for the bulk of its sales. Article

> Research suggests T cells play a protective role in the immune response against dengue fever and should be factored into vaccine design. Study

> Medicago has reported that its H5N1 vaccine was well tolerated in a Phase I trial. Release

> Research firm GlobalData has warned that cost-effectiveness concerns may stop governments from adding Novartis' ($NVS) Bexsero to vaccination programs. Item